Nissen comments on DDMAC's needs to restrict DTC

Steven Nissen, head of cardiovascular medicine at Cleveland Clinic, wrote in the journal Nature that DDMAC “needs the right to restrict direct-to-consumer advertising during the first two years a drug is marketed and to preview advertising to ensure it is not misleading.” Nissen's missive, which also advised reevaluating user fees and nixing the last-minute policy change on off-label reprints, was included in a series advising President Obama. 
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.